Memorial Sloan Kettering Cancer Center, New York, NY.
American Society of Clinical Oncology, Alexandria, VA.
J Clin Oncol. 2022 Dec 1;40(34):3998-4024. doi: 10.1200/JCO.22.01357. Epub 2022 Sep 19.
The aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other health care providers on integrative approaches to managing pain in patients with cancer.
The Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, and patient advocacy representatives. The literature search included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2021. Outcomes of interest included pain intensity, symptom relief, and adverse events. Expert panel members used this evidence and informal consensus to develop evidence-based guideline recommendations.
The literature search identified 227 relevant studies to inform the evidence base for this guideline.
Among adult patients, acupuncture should be recommended for aromatase inhibitor-related joint pain. Acupuncture or reflexology or acupressure may be recommended for general cancer pain or musculoskeletal pain. Hypnosis may be recommended to patients who experience procedural pain. Massage may be recommended to patients experiencing pain during palliative or hospice care. These recommendations are based on an intermediate level of evidence, benefit outweighing risk, and with moderate strength of recommendation. The quality of evidence for other mind-body interventions or natural products for pain is either low or inconclusive. There is insufficient or inconclusive evidence to make recommendations for pediatric patients. More research is needed to better characterize the role of integrative medicine interventions in the care of patients with cancer.Additional information is available at https://integrativeonc.org/practice-guidelines/guidelines and www.asco.org/survivorship-guidelines.
本联合指南旨在为执业医师和其他医疗保健提供者提供循证建议,以采用综合方法治疗癌症患者的疼痛。
肿瘤整合治疗学会和美国临床肿瘤学会召集了一个肿瘤整合治疗、肿瘤内科、肿瘤放射治疗、肿瘤外科、姑息治疗、社会科学、身心医学、护理和患者权益代表的专家小组。文献检索包括 1990 年至 2021 年发表的系统评价、荟萃分析和随机对照试验。感兴趣的结局包括疼痛强度、症状缓解和不良事件。专家小组成员使用这些证据和非正式共识制定了基于证据的指南建议。
文献检索确定了 227 项相关研究,为该指南的证据基础提供了信息。
在成年患者中,应推荐针刺治疗芳香化酶抑制剂相关关节痛。针刺、反射疗法或指压可能对一般癌症疼痛或肌肉骨骼疼痛有效。对于经历程序疼痛的患者,可以推荐催眠。对于接受姑息或临终关怀的疼痛患者,可以推荐按摩。这些建议基于中等水平的证据,受益大于风险,具有中等推荐强度。其他身心干预措施或天然产品治疗疼痛的证据质量要么较低,要么不确定。对于儿科患者,没有足够或不确定的证据来提出建议。需要更多的研究来更好地描述整合医学干预在癌症患者护理中的作用。更多信息可在 https://integrativeonc.org/practice-guidelines/guidelines 和 www.asco.org/survivorship-guidelines 上获得。